CO5180549A1 - DERIVATIVES OF 1-AMINO ETHYLINDOL, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS - Google Patents

DERIVATIVES OF 1-AMINO ETHYLINDOL, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS

Info

Publication number
CO5180549A1
CO5180549A1 CO00026489A CO00026489A CO5180549A1 CO 5180549 A1 CO5180549 A1 CO 5180549A1 CO 00026489 A CO00026489 A CO 00026489A CO 00026489 A CO00026489 A CO 00026489A CO 5180549 A1 CO5180549 A1 CO 5180549A1
Authority
CO
Colombia
Prior art keywords
hydrogen atom
ethylindol
therapeutics
derivatives
amino
Prior art date
Application number
CO00026489A
Other languages
Spanish (es)
Inventor
Philippe Bovy
Patrick Mougenot
Philippo Christophe
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of CO5180549A1 publication Critical patent/CO5180549A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Compuesto de fórmula (I)<EMI FILE="00026489_1" ID="1" IMF=JPEG >en la cual:A representa un átomo de hidrógeno, un halógeno o un hidroxi,B y D representan, independientemente entre sí, un átomo de hidrógeno o un grupo C1-3 alquilo,R1 representa un átomo de hidrógeno, un grupo C1-4 alquilo, C1-2 fluoroalquilo o C1-2 perfluoroalquilo,R2 representa un átomo de hidrógeno, un halógeno, un grupo C1-6 alquilo, C3-6 cicloalquilo, C1-2 perfluoroalquilo, C1-2 perfluoroalquilo o un fenilo,R3 y R4 representan, independientemente entre sí, un átomo de hidrógeno, un halógeno o un grupo C1-6 alquilo,R5 y R6 representan, independientemente entre sí, un átomo de hidrógeno, un grupo C1-6; alquilo o C1-2 fluoroalquilo, o R5 y R6, juntos, forman una cadena C2-7alquileno, y sus sales.Compound of formula (I) <EMI FILE = "00026489_1" ID = "1" MFI = JPEG> in which: A represents a hydrogen atom, a halogen or a hydroxy, B and D represent, independently from each other, an atom of hydrogen or a C1-3 alkyl group, R1 represents a hydrogen atom, a C1-4 alkyl, C1-2 fluoroalkyl or C1-2 perfluoroalkyl group, R2 represents a hydrogen atom, a halogen, a C1-6 alkyl group , C3-6 cycloalkyl, C1-2 perfluoroalkyl, C1-2 perfluoroalkyl or a phenyl, R3 and R4 independently represent each other, a hydrogen atom, a halogen or a C1-6 alkyl group, R5 and R6 independently represent yes, a hydrogen atom, a C1-6 group; alkyl or C1-2 fluoroalkyl, or R5 and R6, together, form a C2-7alkylene chain, and salts thereof.

CO00026489A 1999-04-13 2000-04-11 DERIVATIVES OF 1-AMINO ETHYLINDOL, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS CO5180549A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9904577A FR2792316B1 (en) 1999-04-13 1999-04-13 1-AMINOETHYLINDOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Publications (1)

Publication Number Publication Date
CO5180549A1 true CO5180549A1 (en) 2002-07-30

Family

ID=9544316

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00026489A CO5180549A1 (en) 1999-04-13 2000-04-11 DERIVATIVES OF 1-AMINO ETHYLINDOL, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS

Country Status (7)

Country Link
AR (1) AR023451A1 (en)
AU (1) AU3971400A (en)
CO (1) CO5180549A1 (en)
FR (1) FR2792316B1 (en)
PE (1) PE20010041A1 (en)
UY (1) UY26102A1 (en)
WO (1) WO2000061554A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR077405A1 (en) 2009-07-10 2011-08-24 Sanofi Aventis DERIVATIVES OF INDOL INHIBITORS OF HSP90, COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME FOR THE TREATMENT OF CANCER

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2752840A1 (en) * 1996-08-29 1998-03-06 Synthelabo 7-Amino ethyl benzothiophene derivatives
FR2752839B1 (en) * 1996-08-29 1998-10-09 Synthelabo BENZOFURANE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Also Published As

Publication number Publication date
WO2000061554A1 (en) 2000-10-19
AU3971400A (en) 2000-11-14
FR2792316B1 (en) 2001-06-22
UY26102A1 (en) 2000-10-31
AR023451A1 (en) 2002-09-04
FR2792316A1 (en) 2000-10-20
PE20010041A1 (en) 2001-04-12

Similar Documents

Publication Publication Date Title
CO5180557A1 (en) DERIVATIVES OF 1,4-DIAZABICICLO [3.2.2] NONAN-4-CARBOXYLATES AND CARBOXAMIDS AND THEIR PHARMACEUTICAL COMPOSITIONS.
CO5261539A1 (en) PHARMACEUTICALLY ACTIVE COMPOUNDS
CY1106247T1 (en) THIOPHEN- AND THIAZOLESULFONAMIDES AS ANTINEOPLASTIC AGENTS
CO4970713A1 (en) DERIVATIVES OF CARBOXAMIDOTIAZOLES, THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
EA200500862A1 (en) SYNOMINE AND COMPOUNDS SYNOMENIN, SYNTHESIS AND APPLICATION
ATE302775T1 (en) CARBOLINE DERIVATIVES
CO5590895A2 (en) DERIVATIVES OF SULFONAMIDS, ITS PREPARATION AND ITS APPLICATION AS MEDICATIONS
ATE346067T1 (en) CARBOLINE DERIVATIVES
DE60228990D1 (en) BICYCLIC CONNECTION
RS50229B (en) Vitamin d3 analogs
CO5261538A1 (en) NEW ACIDS (AMINOPROPIL) METHYLPHOSPHINICS
AR027335A1 (en) PIPERIDINE-4-SULFONAMIDE COMPOUNDS, SAME PREPARATION PROCESS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TW427979B (en) A condensed piperidine compound
PT1202954E (en) NEW AMINOBENZOFENONAS
TR200402547T4 (en) A process for preparing pantoprazole and its intermediates.
CO5180549A1 (en) DERIVATIVES OF 1-AMINO ETHYLINDOL, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
JP2003529543A5 (en)
CO4970700A1 (en) PROCESS FOR THE PREPARATION OF SUBSTITUTED PYRIMIDINES
ATE269851T1 (en) BENZIMIDAZOLE DERIVATIVES
CO5210860A1 (en) NEW DERIVATIVES OF PIRIMIDINA-2,4,6-TRIONA
DE60121048D1 (en) PYRAZINOi1&#39;2 &#39;: 1,6öPYRIDOi3,4-BöINDOLDERIVATE
AR040571A1 (en) DERIVATIVES OF ACILOXIPIRROLIDINA, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
TR200000057T2 (en) 6-pyrrolidin-2-ylpyridines, their preparation and therapeutic applications.
DK1347960T3 (en) Process for the preparation of (+/-) trans-4-p-fluorophenyl-3-hydromethyl-1-methylpiperidine
AR023528A1 (en) DERIVATIVES OF CICLOBUTEN-3,4-DIONA, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS

Legal Events

Date Code Title Description
FA Application withdrawn